Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

according to a statement seen by Reuters. Biotech firm Recursion to buy smaller peer Exscientia for $688 million August 8, 2024 Merck KGaA is seeing a faster-than-expected improvement in its ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in previous studies, the drugmaker said on Thursday.

Robert F. Kennedy Jr., who awaits confirmation as Donald Trump's Health and Human Services secretary, helped organize mass ...

Merck said on Tuesday it would not ship its ... Pfizer's bladder cancer therapy meets main goal in late-stage study Reuters, the news and media division of Thomson Reuters, is the world’s ...

Jan 24 (Reuters) - Merck (MRK.N), opens new tab and Japan-based Eisai (4523.T), opens new tab said on Friday a combination of their therapies failed to extend the lives of patients with a type of ...

The CEO of Germany's Merck KGaA on Thursday said a recovery in sales growth at its existing business means it can take a cautious approach to buying other companies, which are expensively priced.

British defence group Babcock on Thursday hiked its revenue expectations for the year to around 4.9 billion pounds ($6.11 billion), on the back of strength in its nuclear and marine segments.